Oxytocin (Pitocin)
Oxytocin (OXT)
Approved status applies to specific products, routes, and indications, not every use context discussed online.
An FDA-approved hormone injection (Pitocin) used in hospitals to start or strengthen labor contractions and to prevent excessive bleeding after delivery. It is also the brain's natural 'social bonding hormone,' being investigated for autism, schizophrenia, and other conditions, though no new uses have been officially confirmed yet.
Safety Summary
The side effect profile differs substantially by route and indication. Obstetric IV use carries the highest risk (uterine hyperstimulation, water intoxication, fetal distress). Intranasal use in research settings shows a mild, mostly placebo-comparable profile (headache, nasal irritation). Community subcutaneous use reports are anecdotal. Prolonged intrapartum IV infusion can cause functional desensitization of uterine oxytocin receptors, paradoxically increasing risk of uterine atony and postpartum hemorrhage. Chronic intranasal use (weeks) in small trials was generally well-tolerated with no clinically significant tolerance or withdrawal. No abuse potential or dependence reported; FDA label NDA018248.
Clinical check-in
If real-world use or exposure is being considered, review potential interactions, contraindications, and monitoring needs with a licensed clinician rather than relying on summary copy alone.
Sources: [1-11]